Search - tctmd.com

Displaying 181 - 200 of 561

Sort: Relevancy | Date

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

Presentation TCT 2014

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Anthony H. Gershlick

September 14, 2014

Presentation TCT 2014

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Renu Virmani

September 14, 2014

Presentation TCT 2014

Treatment Options for BMS and DES ISR: What Works Best?

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Are Current DES Really Safer Than BMS?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

Presentation TCT 2014

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

Presenter: Renu Virmani

September 13, 2014

Presentation TCT 2014

The Concept of the COBRA PzF-Shielded Stent

Presenter: Renu Virmani, Donald Cutlip

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Daily News

欧洲学会发布更新后的CAD血运重建指南

L.A. McKeown

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

L.A. McKeown

September 02, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

Advertisement

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Keynote Address Focuses on Newer DES, Problematic Subgroups

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Treatment Options for BMS and DES ISR: What Works Best?

Are Current DES Really Safer Than BMS?

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

The Concept of the COBRA PzF-Shielded Stent

DCB in BMS vs DES ISR: Insights from the RIBS Trials

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

欧洲学会发布更新后的CAD血运重建指南

European Societies Release Updated Revascularization Guidelines for CAD

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content